What Makes BioMarin (BMRN) so Attractive
As of February 12 closing, BioMarin Pharmaceutical (NASDAQ:BMRN) carried a moderately bullish analyst sentiment.
11 Best Bitcoin and Blockchain Stocks to Invest in
Bitcoin plummeted below $61,000 on February 5, reversing all gains since US President Donald Trump's election in November 2024, as reported by Reuters on February 7, 2026.
Hedge Funds
News & Analysis
Top Fund Managers
Best Performing Funds
Featured Content
Insider Trading
News & Analysis
Latest Insider Purchases
Thakur bought 326,875 K2 Capital Acquisition Corp shares at $0.00
K2 bought 326,875 K2 Capital Acquisition Corp shares at $0.00
Mitsui bought 280 Berkley W R Corp shares at $71.18
Mitsui bought 4,314 Berkley W R Corp shares at $70.30
Mitsui bought 15,406 Berkley W R Corp shares at $69.73
Latest Insider Sales
Manchester sold 225,000 Roivant Sciences Ltd. shares at $26.50
Manchester sold 150,784 Roivant Sciences Ltd. shares at $26.49
Manchester sold 275,000 Roivant Sciences Ltd. shares at $26.76
Manchester sold 150,000 Roivant Sciences Ltd. shares at $26.72
Manchester sold 425,000 Roivant Sciences Ltd. shares at $26.67
Featured Content
Do not Miss
Summit Therapeutics (SMMT) Grabs Investor Attention After Major FDA Breakthrough
As of the close of play on February 12, consensus sentiment around Summit Therapeutics (NASDAQ:SMMT) was moderately bullish.
FDA Guidance on MRD Negativity Bodes Well for Legend Biotech (LEGN)
On January 20, Leonid Timashev of RBC Capital maintained an Outperform rating on Legend Biotech (NASDAQ:LEGN) and set a $66 price target.
Soleno Therapeutics (SLNO) Sparks Confidence Amid Topline Outperformance
On January 20, the price target on Soleno Therapeutics (NASDAQ:SLNO) was increased from $110 to $120 by Ram Selvaraju from H.C. Wainwright.
FDA-Issued CRL for Relacorilant NDA Leads to Bullish Views Around Corcept Therapeutics (CORT)
On February 2, Edward Nash from Canaccord Genuity reaffirmed his Buy rating for Corcept Therapeutics (NASDAQ:CORT).
Strong Rare Disease Pipeline Drives Favorable Sentiment for Ultragenyx (RARE)
On February 3, the price target on Ultragenyx Pharmaceutical (NASDAQ:RARE) was set to $60 by H.C. Wainwright analyst Ram Selvaraju, who maintained a Buy rating on the stock.
Wave Life Sciences (WVE) to Benefit From Optimism Surrounding Alpha-1 Antitrypsin Deficiency Program
As of the February 12 closing, consensus sentiment around Wave Life Sciences (NASDAQ:WVE) remained strongly bullish. The stock received coverage from 15 analysts, all of whom assigned Buy ratings.
Dyne Therapeutics (DYN) Attains Orphan Drug Designation From Japanese Ministry
As of the February 12 closing, Dyne Therapeutics (NASDAQ:DYN) held a strongly bullish consensus view. Of the 9 analysts covering the stock, 7 assigned Buy ratings and 2 issued Hold ratings.
Impressive Clinical Pipeline Leads to Bullish Sentiment for Vaxcyte (PCVX)
On January 23, Cantor Fitzgerald maintained its Overweight rating on Vaxcyte Incorporated (NASDAQ:PCVX), highlighting continued progress across the company’s clinical pipeline.
Stifel Initiates Coverage on Olema Pharmaceuticals (OLMA) With Buy Rating
On February 11, Laura Prendergast of Stifel Nicolaus initiated coverage of Olema Pharmaceuticals (NASDAQ:OLMA).
Here is Why Beam Therapeutics (BEAM) Appears so Attractive
On January 22, Patrick Trucchio from H.C. Wainwright maintained a Buy rating on Beam Therapeutics (NASDAQ:BEAM), with a price target of $80.
Guggenheim Raises Price Target for Praxis Precision Medicines (PRAX)
On February 10, Guggenheim analyst Yatin Suneja raised the price target on Praxis Precision Medicines (NASDAQ:PRAX) from $760 to $800.
Orexin-2 Receptor Data Reinforces a Positive Outlook for Centessa (CNTA)
On January 29, Danielle Brill from Truist Financial raised her price target on Centessa Pharmaceuticals (NASDAQ:CNTA) from $33 to $38 and assigned a Buy rating to the stock.
Spyre Therapeutics (SYRE) Set POC Readout Priorities for 2026
As of the close of play on February 12, consensus sentiment around Spyre Therapeutics (NASDAQ:SYRE) was strongly bullish.
Atacicept’s Potential Approval Drives Favorable Views on Vera Therapeutics (VERA)
Rama believes the shares offer strong upside potential from the current trading range.
Arcellx (ACLX) Shares Encouraging Data on Latest Laboratory Study
On February 12, Qize Ding from Rothschild & Co Redburn downgraded the rating on Arcellx Incorporated (NASDAQ:ACLX) from Buy to Neutral.
Here is Why Apogee Therapeutics (APGE) Appears Attractive
Selloff in Apogee Therapeutics (APGE) stock, following the release of Sanofi’s Phase 3 amlitelimab data, is viewed as a market overreaction by Meacham.
UBS Still Neutral on East West Bank (EWBC)
UBS, on February 4, marginally trimmed its target price on East West Bancorp (EWBC) to $125 (from $126).
UBS Retained Buy Recommendation on SouthState Bank (SSB)
On February 4, UBS slightly increased its target price on SouthState Bank (SSB) to $121 (from $120) and reiterated its Buy recommendation.
Commerce Bank (CBSH) Declares Dividends of $0.2750 per Share
On February 6, the board of directors of Commerce Bancshares (CBSH) declared a quarterly dividend of $0.2750 per share.
UBS Keeps Buy Rating on Western Alliance (WAL)
On February 4, UBS trimmed its target price on Western Alliance (WAL) by 0.9% to $106 (from $107) but retained its Buy recommendation on the stock.
JP Morgan Increases Target Price on Huntington Bancshares (HBAN) to $21
On February 9, JPMorgan analyst Andrew Dietrich raised his target price on Huntington Bancshares by 5.0% to $21 (from $20) and kept his Overweight call on the stock.
Evercore ISI Raises Price Target on Pinnacle Financial (PNFP) to $116, Keeps Overweight Call
On February 6, Evercore ISI raised its target price on Pinnacle Financial by 0.9% to $116 (from $115) and retained its Outperform call on the stock.
JP Morgan Raises Target Price on Truist Financial (TFC) to $47, Keeps Neutral Call
On February 9, JPMorgan analyst Vivek Juneja raised his target price on Truist Financial by 10.7% to $57.00 (from $51.50) but maintained his Neutral rating on the stock.
JP Morgan Overweight on BNY Mellon (BK) with a Target Price of $128.50
JPMorgan raised its target price on BNY Mellon by 2.8% to $128.50 (from $125.00), while reiterating the firm’s Overweight call on the stock.
Baird Upgrades Wells Fargo (WFC) to Neutral
Baird, on February 13, upgraded Wells Fargo to a Neutral (from Underperform). Despite the rating upgrade, the firm did not change its $85 target price on the company.
JP Morgan Raises Target Price on Citi (C), Keeps Overweight Call
On February 9, JPMorgan raised its target price on Citi by 3.1% to $134 (from $130), reiterating its Overweight rating on the stock.
Taiwan Semiconductor Manufacturing (TSM) Positioned to Benefit From AI Demand and Potential Pricing Power
Sands Capital Management, LLC's Technology Innovators Fund released its Q4 2025 investor letter for "Technology Innovators Fund". A copy of the letter can be downloaded here.
Swiss Firmup Launches as a Prop Firm Focused on Transparent Futures Trading
Swiss Firmup today announces its launch as a proprietary trading firm dedicated to supporting independent traders operating in the global financial derivatives markets.
Liquidia Corporation (LQDA) Gains Momentum Following Overturning of District Court Patent Ruling
Arquitos Capital Partners, an investment management firm, released its Q4 2025 investor letter. A copy of the letter can be downloaded here.
Fabrinet (FN) Advances as Optical Hardware Demand Strengthens
Wasatch Global Investors, an asset management company, released its "Small Cap Growth Strategy" Q4 2025 investor letter. A copy of the letter can be downloaded here.
JFrog (FROG) Gains Momentum Following 26% Revenue Growth Beat
Wasatch Global Investors, an asset management company, released its "Small Cap Growth Strategy" Q4 2025 investor letter. A copy of the letter can be downloaded here.
Trex Company (TREX) Under Pressure as Housing Weakness Impacts Outdoor Living Demand
Wasatch Global Investors, an asset management company, released its "Small Cap Growth Strategy" Q4 2025 investor letter. A copy of the letter can be downloaded here.
Shift4 Payments (FOUR) Remains in Focus Amid Volatility in Payment Technology Stocks
Wasatch Global Investors, an asset management company, released its "Small Cap Growth Strategy" Q4 2025 investor letter. A copy of the letter can be downloaded here.
Vital Farms (VITL) Faces Short-Term Pressure Despite Continued Demand for Ethical Food Products
Wasatch Global Investors, an asset management company, released its "Small Cap Growth Strategy" Q4 2025 investor letter. A copy of the letter can be downloaded here.
Hedge Fund Resource Center Lists
7 Most Promising Psychedelic Stocks According to Hedge Funds
7 Cheap Pharmaceutical Stocks to Buy According to Hedge Funds
15 Innovative Healthcare Stocks to Buy According to Analysts
9 High Growth Small Cap Stocks That Are Profitable
20 Most Profitable Stocks of the Last 20 Years
15 High Growth Mid-Cap Stocks to Buy
Top 10 Oncology Stocks to Buy Now
10 Best Investments During A Recession
7 Best Rare Earth Stocks to Buy According to Hedge Funds
Barclays Turns More Bullish on 10x Genomics, Inc. (TXG) Despite Uneven Research Spending
New Product Launch Strengthens Bull Case for Twist Bioscience ( TWST)
J.P. Morgan Lifts Natera, Inc. (NTRA) Target on Signatera Momentum
11 Best Cancer Stocks to Buy Right Now
40 Most Unfriendly Countries in the World
30 Unhappiest Countries in the World in 2025
Moderna, Inc. (MRNA) Reports Strong H5 Avian Flu Vaccine Data Despite HHS Funding Cut
5 Countries with the Most Beautiful Women in the World
20 Countries with the Most Beautiful Women in the World
20 US Cities with the Highest Homeless Population Per Capita
20 Countries with the Highest Homeless Population
12 Countries with the Highest Bond Yields in the World
20 Countries with the Most Battle Tanks in the World
12 Best Nasdaq Stocks Under $20 to Buy Now
10 Best Low Beta Tech Stocks to Buy According to Analysts
10 Worst Performing Currencies of 2024
15 States with the Best Weed in America
16 Countries with the Largest Proven Oil Reserves in the World
16 Highest Quality Chocolate Brands in the US
20 Countries with the Strongest Armies in the World
Top 13 English Speaking Countries in Asia
20 States with Highest Female to Male Ratio in the US
40 Best Places to Visit in Europe Before You Die
20 States with the Lowest Life Expectancy in the US
25 Cities with the Highest Homeless Population in the World
20 Countries With The Best English Accent in The World
30 Cities with the Highest Weed Consumption in the US
25 Countries with the Highest Alcohol Consumption per Capita
10 Best Gold Stocks Under $30
10 Best Genomics Stocks To Buy Right Now
20 Countries with the Best Economy in the World in 2024
30 Cheapest Countries in the World in 2024
15 Healthiest Countries in Europe
15 Healthiest Countries In Africa
25 Most Tropical Cities in the US
15 Most Underrated States in the US
13 Best Cheap Perfumes for Women That Smell Amazing
Best Cheap Perfume for Women That Smells Amazing
20 Most Industrialized Countries in Asia
The Most Successful Celebrity Beauty Company in the World
15 Most Successful Celebrity Beauty Companies in the World
